Literature DB >> 19533837

Mifepristone and Misoprostol for the management of placenta accreta - a new alternative approach.

M Morgan1, R Atalla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19533837     DOI： 10.1111/j.1471-0528.2009.02159.x

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  3 in total

1.  Management of postpartum pulmonary embolism combined with retained placenta accreta: A case report.

Authors:  An Tong; Fumin Zhao; Ping Liu; Xia Zhao; Xiaorong Qi
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 2.  Acute trophoblastic pulmonary embolism during conservative treatment of placenta accreta: case report and review of literature.

Authors:  Qiu-Ming Wang; Hui-Li Liu; Qun Dang
Journal:  Eur J Med Res       Date:  2015-11-14       Impact factor: 2.175

3.  Management strategies for patients with placenta accreta spectrum disorders who underwent pregnancy termination in the second trimester: a retrospective study.

Authors:  Ran Cui; Menghui Li; Junli Lu; Huimin Bai; Zhenyu Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2018-07-11       Impact factor: 3.007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.